<code id='7DD029567E'></code><style id='7DD029567E'></style>
    • <acronym id='7DD029567E'></acronym>
      <center id='7DD029567E'><center id='7DD029567E'><tfoot id='7DD029567E'></tfoot></center><abbr id='7DD029567E'><dir id='7DD029567E'><tfoot id='7DD029567E'></tfoot><noframes id='7DD029567E'>

    • <optgroup id='7DD029567E'><strike id='7DD029567E'><sup id='7DD029567E'></sup></strike><code id='7DD029567E'></code></optgroup>
        1. <b id='7DD029567E'><label id='7DD029567E'><select id='7DD029567E'><dt id='7DD029567E'><span id='7DD029567E'></span></dt></select></label></b><u id='7DD029567E'></u>
          <i id='7DD029567E'><strike id='7DD029567E'><tt id='7DD029567E'><pre id='7DD029567E'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:1432
          Robert F. Kennedy Jr.
          Robert F. Kennedy Jr. arrives in the lobby of Trump Tower in New York for a meeting with President-elect Donald Trump. Evan Vucci/AP

          WASHINGTON — Outspoken vaccine critic Robert Kennedy Jr. said Tuesday that he had accepted a position in Donald Trump’s administration as chair of a panel on vaccine safety and scientific integrity, in what would be the clearest sign yet of the president-elect’s suspicions about vaccines.

          Kennedy’s remarks followed his meeting with the president-elect at Trump Tower and immediately sparked outrage from scientists, pediatricians, and public health experts, who fear the incoming administration could give legitimacy to skeptics of childhood immunizations despite a huge body of scientific research demonstrating that vaccines are safe. Many of those skeptics believe vaccines are a cause of autism.

          advertisement

          Hours later, Trump spokeswoman Hope Hicks said in a statement that the president-elect was “exploring the possibility of forming a commission on Autism,” but said “no decisions have been made at this time.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Dario to buy mental health app maker Twill in cash and stock deal
          Dario to buy mental health app maker Twill in cash and stock deal

          AdobeDarioHealth,whichmakesappsformanagingchronicdiseases,todayannounceditwillacquiredigitalmentalhe

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Annovis Bio delivers candor, but not confidence, on Parkinson’s study

          MollyFerguson/STATAnnovisBiohadmybiotechbull%^&!meterrunningredafteritmadealatechangetothedesign